Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure

Genetics and Molecular Research

Volumn 13, Issue 1, 2014, Pages 323-335

  Gu, X S ^a   Wang, Z B ^b   Ye, Z ^c   Lei, J P ^c   Li, L ^b   Su, D F ^b   Zheng, X ^c  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AMPK; Heart failure; Resveratrol; SIRT1

Indexed keywords

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; CELLS, CULTURED; HEART FAILURE; MALE; MICE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NIACINAMIDE; RATS; SIRTUIN 1; STILBENES; UP-REGULATION; VENTRICULAR FUNCTION;

EID: 84893909601     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.January.17.17     Document Type: Article

References (30)

1. Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, et al. (2004). Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ. Res. 95: 971-980.
2. Alcendor RR, Gao S, Zhai P, Zablocki D, et al. (2007). Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100: 1512-1521.
3. Beauloye C, Bertrand L, Horman S and Hue L (2011). AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc. Res. 90: 224-233.
4. Behbahani J, Thandapilly SJ, Louis XL, Huang Y, et al. (2010). Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat. Am. J. Hypertens. 23: 1273-1278.
5. Cheng HL, Mostoslavsky R, Saito S, Manis JP, et al. (2003). Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 100: 10794-10799.
6. Cho IR, Koh SS, Malilas W, Srisuttee R, et al. (2012). SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of beta-catenin. Biochem. Biophys. Res. Commun. 423: 270-275.
7. Coussens M, Maresh JG, Yanagimachi R, Maeda G, et al. (2008). Sirt1 deficiency attenuates spermatogenesis and germ cell function. PLoS One 3: e1571.
8. Dekkers DH, Bezstarosti K, Gurusamy N, Luijk K, et al. (2008). Identification by a differential proteomic approach of the induced stress and redox proteins by resveratrol in the normal and diabetic rat heart. J. Cell Mol. Med. 12: 1677-1689.
9. Ghanim H, Sia CL, Korzeniewski K, Lohano T, et al. (2011). A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J. Clin. Endocrinol. Metab. 96: 1409-1414.
10. Hung LM, Chen JK, Huang SS, Lee RS, et al. (2000). Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47: 549-555.
11. Hwang JT, Kwon DY, Park OJ and Kim MS (2008). Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells. Genes Nutr. 2: 323-326.
12. Imai S, Armstrong CM, Kaeberlein M and Guarente L (2000). Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403: 795-800.
13. Jiang S, Wang W, Miner J and Fromm M (2012). Cross regulation of sirtuin 1, AMPK, and PPARgamma in conjugated linoleic acid treated adipocytes. PLoS One 7: e48874.
14. Kim MS and Lee KU (2005). Role of hypothalamic 5'-AMP-activated protein kinase in the regulation of food intake and energy homeostasis. J. Mol. Med. 83: 514-520.
15. Lu D, Ma Y, Zhang W, Bao D, et al. (2012). Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice. Hypertension 60: 81-89.
16. Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, et al. (2010). SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 285: 8340-8351.
17. Penumathsa SV, Thirunavukkarasu M, Zhan L, Maulik G, et al. (2008). Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J. Cell Mol. Med. 12: 2350-2361.
18. Ramamurthy S and Ronnett GV (2006). Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain. J. Physiol. 574: 85-93.
19. Rojas M, Meredith D, Kylander J, Barrick D, et al. (2008). Echocardiography under isoflurane anesthesia affects heart rate and function in commonly utilized mouse strains. FASEB 22: 970-944.
20. Shin JA, Lee KE, Kim HS and Park EM (2012). Acute resveratrol treatment modulates multiple signaling pathways in the ischemic brain. Neurochem. Res. 37: 2686-2696.
21. Sulaiman M, Matta MJ, Sunderesan NR, Gupta MP, et al. (2010). Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 298: H833-H843.
22. Thandapilly SJ, Wojciechowski P, Behbahani J, Louis XL, et al. (2010). Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am. J. Hypertens. 23: 192-196.
23. Thirunavukkarasu M, Penumathsa SV, Koneru S, Juhasz B, et al. (2007). Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic. Biol. Med. 43: 720-729.
24. Turdi S, Fan X, Li J, Zhao J, et al. (2010). AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction. Aging Cell 9: 592-606.
25. Turdi S, Kandadi MR, Zhao J, Huff AF, et al. (2011). Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J. Mol. Cell Cardiol. 50: 712-722.
26. Wang QD, Tokuno S, Valen G, Sjoquist PO, et al. (2002). Cyclic fluctuations in the cardiac performance of the isolated Langendorff-perfused mouse heart: pyruvate abolishes the fluctuations and has an anti-ischaemic effect. Acta Physiol. Scand. 175: 279-287.
27. Wojciechowski P, Juric D, Louis XL, Thandapilly SJ, et al. (2010). Resveratrol arrests and regresses the development of pressure overload-but not volume overload-induced cardiac hypertrophy in rats. J. Nutr. 140: 962-968.
28. Zaha VG and Young LH (2012). AMP-activated protein kinase regulation and biological actions in the heart. Circ. Res. 111: 800-814.
29. Zhang C, Feng Y, Qu S, Wei X, et al. (2011a). Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53. Cardiovasc. Res. 90: 538-545.
30. Zhang CX, Pan SN, Meng RS, Peng CQ, et al. (2011b). Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats. Clin. Exp. Pharmacol. Physiol. 38: 55-62.